Jamie Hoel is a biostatistician and the Office Director for the Boston and Madison offices at Frontier Science, where he provides biostatistical oversight and direction for projects across the organization. He has over 20 years of clinical trials experience, working primarily in the field of interim data monitoring, and has worked on a wide variety of statistical analyses, including nonparametric methods, Kaplan Meier estimates, futility analyses, conditional power calculations, O’Brien-Fleming monitoring boundaries, Inverse Probability of Censoring Weighting, and projections for event driven trials.

His experience also spans many different disease areas, including relapsing multiple sclerosis, secondary hyperparathyroidism, atrial fibrillation, atrial flutter, acute decompensated heart failure, dyslipidemia, breast cancer, Clostridium difficile-associated diarrhea, diabetes, insomnia, pulmonary arterial hypertension, HIV, and ulcerative colitis. Jamie holds a Master’s of Science in Biostatistics from the University of Minnesota.